Bilaketaren emaitzak - Reardon, David A

Cilengitide: A Prototypic Integrin Inhibitor for the Treatment of Glioblastoma and Other Malignancies nork Reardon, David A., Cheresh, David

Testu osoa Testu osoa Testu osoa

Treatment options and outcomes for glioblastoma in the elderly patient nork Arvold, Nils D, Reardon, David A

Testu osoa Testu osoa Testu osoa

A Review of Micro and Macro Vascular Analyses in the Assessment of Tumor-Associated Vasculature as Visualized by MR nork Bullitt, Elizabeth, Reardon, David A., Smith, J. Keith

Testu osoa Testu osoa Testu osoa

Current available therapies and future directions in the treatment of malignant gliomas nork Desjardins, Annick, Reardon, David A, Vredenburgh, James J

Testu osoa Testu osoa

Efficacy and safety of immune checkpoint blockade for brain metastases nork Harary, Maya, Reardon, David A, Iorgulescu, J Bryan

Testu osoa Testu osoa Testu osoa

Targeted molecular therapies against epidermal growth factor receptor: Past experiences and challenges nork Reardon, David A., Wen, Patrick Y., Mellinghoff, Ingo K.

Testu osoa Testu osoa Testu osoa

Experience with irinotecan for the treatment of malignant glioma nork Vredenburgh, James J., Desjardins, Annick, Reardon, David A., Friedman, Henry S.

Testu osoa Testu osoa Testu osoa

Cilengitide: an integrin-targeting arginine-glycine-aspartic acid peptide with promising activity for glioblastoma multiforme nork Reardon, David A, Nabors, L Burt, Stupp, Roger, Mikkelsen, Tom

Testu osoa Testu osoa Testu osoa

PD-1 inhibitors: Do they have a future in the treatment of glioblastoma? nork Khasraw, Mustafa, Reardon, David A., Weller, Michael, Sampson, John H.

Testu osoa Testu osoa Testu osoa

Pitfalls in the Neuroimaging of Glioblastoma in the Era of Antiangiogenic and Immuno/Targeted Therapy – Detecting Illusive Disease, Defining Response nork Huang, Raymond Y., Neagu, Martha R., Reardon, David A., Wen, Patrick Y.

Testu osoa Testu osoa Testu osoa

Immunotherapy for glioblastoma: going viral nork Iorgulescu, J. Bryan, Reardon, David A., Chiocca, E. Antonio, Wu, Catherine J.

Testu osoa Testu osoa Testu osoa

Glioblastoma multiforme: an emerging paradigm of anti-VEGF therapy nork Reardon, David A, Wen, Patrick Y, Desjardins, Annick, Batchelor, Tracy T, Vredenburgh, James J

Testu osoa Testu osoa Testu osoa

A dose escalation trial for the combination of erlotinib and sirolimus for recurrent malignant gliomas nork Nghiemphu, Phioanh Leia, Lai, Albert, Green, Richard M., Reardon, David A., Cloughesy, Timothy

Testu osoa Testu osoa Testu osoa

Antiangiogenic Therapy for Glioblastoma: Current Status and Future Prospects nork Batchelor, Tracy T., Reardon, David A., de Groot, John F., Wick, Wolfgang, Weller, Michael

Testu osoa Testu osoa Testu osoa

Prospects of immune checkpoint modulators in the treatment of glioblastoma nork Preusser, Matthias, Lim, Michael, Hafler, David A., Reardon, David A., Sampson, John H.

Testu osoa Testu osoa Testu osoa

Targeted α-Particle Radiotherapy with (211)At-labeled Monoclonal Antibodies nork Zalutsky, Michael R., Reardon, David A., Pozzi, Oscar R., Vaidyanathan, Ganesan, Bigner, Darell D.

Testu osoa Testu osoa Testu osoa

Progression-free survival as a surrogate endpoint for overall survival in glioblastoma: a literature-based meta-analysis from 91 trials nork Han, Kelong, Ren, Melanie, Wick, Wolfgang, Abrey, Lauren, Das, Asha, Jin, Jin, Reardon, David A.

Testu osoa Testu osoa Testu osoa

Impact of imaging measurements on response assessment in glioblastoma clinical trials nork Reardon, David A., Ballman, Karla V., Buckner, Jan C., Chang, Susan M., Ellingson, Benjamin M.

Testu osoa Testu osoa Testu osoa

Interpretation of meta-analysis evaluating progression-free survival as a surrogate endpoint for overall survival in glioblastoma nork Han, Kelong, Ren, Melanie, Wick, Wolfgang, Abrey, Lauren, Das, Asha, Jin, Jin, Reardon, David A.

Testu osoa Testu osoa Testu osoa

Advanced MRI assessment to predict benefit of anti-programmed cell death 1 protein immunotherapy response in patients with recurrent glioblastoma nork Qin, Lei, Li, Xiang, Stroiney, Amanda, Qu, Jinrong, Helgager, Jeffrey, Reardon, David A., Young, Geoffrey S.

Testu osoa Testu osoa Testu osoa